Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes
Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimers, despite two major trials last month that found an older drug similar to Ozempic had no effect in slowing early-stage disease
Can GLP-1 medications be used for PCOS
Each component is studied in experimental systems for roles relevant to tissue repair, extracellular matrix regulation, angiogenic signaling, and inflammatory modulation
Melatonin injections (10 mg/kg) prior to acetaminophen overdose may be more effective than rescue doses for reducing liver toxicity (Kanno 2006), although rescue treatments at this same dose have been shown to effectively protect kidney tissue from cell death (Ilbey 2009)
Ultimately, patience and realistic goal-setting are crucial
